Restores Aβ Clearance by Overcoming PCSK9–LRP1 Dysregulation and TRIB3‐Mediated Autophagy Blockade in Alzheimer's Disease
Jie Miao, Jing Wang, Yankun Li, Haipei Zhang, Yanli Zhang, Qingnian Li, Bo Xiao, Wenhu Zhou, Junhong Guo · 2026
Read Restores Aβ Clearance by Overcoming PCSK9–LRP1 Dysregulation and TRIB3‐Mediated Autophagy Blockade in Alzheimer's Disease by Jie Miao, Jing Wang, Yankun Li, Haipei Zhang, Yanli Zhang, Qingnian Li, Bo Xiao, Wenhu Zhou, Junhong Guo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13624319.txt.
Description
Jie Miao leads a study attacking Alzheimer's disease at the brain's border, where a clogged clearance system lets toxic amyloid-beta pile up. Brain blood vessel cells ferry it out through a transporter, but the team found two blocks: a regulatory protein that disables the transporter. A stress protein jams the cell's recycling so it cannot be broken down.
Silencing the first blocker restored the transporter and improved export; silencing the second reopened the recycling pathway and let cells digest their load. Researchers packaged gene-silencing strands against both targets into tea-based nanoparticles with a homing coat, which crossed into the brain and concentrated in vessel cells and immune cells. In Alzheimer's-model mice, six weeks of treatment sharpened cognition, cut amyloid and vessel deposits, and calmed inflammation without short-term harm. The paired approach, export plus digestion, is offered as a clearance therapy template.
Catalog record
| CREATOR | Jie Miao, Jing Wang, Yankun Li, Haipei Zhang, Yanli Zhang, Qingnian Li, Bo Xiao, Wenhu Zhou, Junhong Guo |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 108 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |